Prototype Tool Leverages AI to Predict Which COVID-19 Patients Most Likely to Develop Severe Symptoms
The tool indicated that a combination of small changes in levels of the liver enzyme alanine aminotransferase (ALT), patient-reported myalgia (aching muscles), and raised hemoglobin levels, most accurately predicted the development severe disease.
![ArcherDX said its Archer Immunoverse and VariantPlex NGS assays will be used by Ambry toward offering its biopharma customers large-scale immune repertoire analysis and chimeric antigen T-cell receptor (CAR-T) manufacturing characterization and pharmacodynamics. [royaltystockphoto/Getty Images]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1550-100x70.jpeg "Removing EGR4 “Brake” on Immune Activation May Be Viable I/O Therapeutic Approach")
Cancer Gets a Global Genomic Map
The Pan-Cancer Analysis of Whole Genomes incorporated 2,658 whole genomes, 38 tumor types, 1,188 transcriptomes, and 1,300 scientists from 37 countries.
Clinical Combinations
Clinicians pursue combining genotypes with phenotypes to provide more precise healthcare.
The Accelerating Race for Immunotherapy Biomarkers
As the market for immunotherapies grows, doctors’ interest in diagnostics to guide more precise treatment increases.
Of Known Significance
An exclusive Clinical OMICs conversation with the director of Genomes2People, Robert Green, M.D., MPH.
Comprehesive Approach
Epic Sciences has retooled its management team and combined CTC and ctDNA technologies in its pursuit of comprehensive cancer profiling.
COVID-19 Patients May Carry Virus after Symptoms Have Resolved
The study found that the incubation period of the virus was five days for all but one of the patients, and the average duration of symptoms was eight days. However, the length of time that patients remained contagious after resolution of their symptoms ranged from one to eight days.
ACE inhibitors and Angiotensin Receptor Blockers May Increase Mortality Rate In Elderly COVID-19 Patients
These highly prescribed medications change cell surface protein expression, which is particularly problematic in cells in the respiratory system—tissue that is vulnerable to targeting and attack by the COVID-19 virus.
Moderna Charts Fast Track of SARS-CoV-2 Vaccine to Clinical Trials
As Moderna's vaccine development moves at unprecedented speed, the company's CEO explains how they have moved so quickly and why he is hopeful that their pace will continue.
Stanford Researchers Dig Into Community Spread of COVID-19
The researchers explain why it is an urgent matter for environmental engineers and scientists to collaborate on pinpointing viral and environmental characteristics that affect COVID-19 transmission via surfaces, the air, and fecal matter.
Abbott Launching ID NOW COVID-19 Tests, Offering Positive Results in Five Minutes
Company expects to deliver 50,000 tests per day of the rapid, instrument-based, isothermal system designed for qualitative detection of infectious diseases.
Prototype Tool Leverages AI to Predict Which COVID-19 Patients Most Likely to Develop Severe Symptoms
The tool indicated that a combination of small changes in levels of the liver enzyme alanine aminotransferase (ALT), patient-reported myalgia (aching muscles), and raised hemoglobin levels, most accurately predicted the development severe disease.
New Study Suggests COVID-19 Reinfection Unlikely
The study used four adult Chinese rhesus macaques and found that those monkeys that had been re-exposed to SARS-CoV-2, like the unexposed control monkey, showed no recurrence of COVID-19.
COVID-19 Symptom Checker for Individual Monitoring
COVID-19 Compass is based on CDC guidelines, best clinical practices, illness severity, and risk factors such as age, gender, location, potential exposure and pre-existing health conditions.
Largest Study to Date of COVID-19 Susceptibility Launched
Researchers will launch the study involving 1,000 subjects—consisting of COVID-19 patients and their partners and first-degree relatives as controls—to compare a variety of genomic and other biological variables between those patients who show no or mild symptoms and those who show severe illness.
New Institute to Seek AI-Based Solutions to Curbing COVID-19 Pandemic
C3.ai DTI will focus its research on AI, machine learning, the internet of things, big data analytics, human factors, organizational behavior, ethics, and public policy.
